The impact of syndromic treatment of sexually transmitted diseases on genital shedding of HIV-1

AIDS

Volumn 18, Issue 5, 2004, Pages 781-785

  Wolday, Dawit ^a,f   Gebremariam, Zeru ^b   Mohammed, Zemzem ^c   Dorigo Zetsma, Wendelien ^a   Meles, Hailu ^a   Messele, Tsehaynesh ^a   Geyid, Aberra ^d   Sanders, Eduard ^a   Maayan, Shlomo ^e  

^a Ethio Netherlands AIDS Res Proj   (Israel)

^b Black Lion Teaching Hospital   (Israel)

^c Tekle Haymanot Health Center   (Israel)

^d ETHIOPIAN PUBLIC HEALTH INSTITUTE   (Ethiopia)

^e HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^f Ethio Netherlands AIDS Research Project ENARP   (Ethiopia)

Author keywords

Cervical HIV shedding; Developing countries; HIV; Sexually transmitted diseases; STD syndromic treatment

Indexed keywords

ANTIRETROVIRUS AGENT; BENZATHINE PENICILLIN; CD4 ANTIGEN; DOXYCYCLINE; ERYTHROMYCIN; METRONIDAZOLE; NYSTATIN; RNA; STREPTOMYCIN; VIRUS RNA;

ADULT; ARTICLE; CELL COUNT; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG RESPONSE; FEMALE; GENDER; GENERAL CONDITION IMPROVEMENT; GENITAL DISCHARGE SYNDROME; GENITAL SYSTEM; GENITAL ULCER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MEASUREMENT; PALLIATIVE THERAPY; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; SYMPTOMATOLOGY; SYNDROME; T LYMPHOCYTE; TREATMENT FAILURE; UTERINE CERVIX; VIRUS LOAD; VIRUS SHEDDING;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CERVIX UTERI; CHI-SQUARE DISTRIBUTION; CLINICAL PROTOCOLS; DEVELOPING COUNTRIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MIDDLE AGED; RNA, VIRAL; SEXUALLY TRANSMITTED DISEASES; VIRAL LOAD; VIRUS SHEDDING;

EID: 2042449094     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200403260-00009     Document Type: Article

References (20)

1. Moss GB, Overbaugh J, Welch M, Reilly M, Bwayo J, Plummer FA, et al. Human immunodeficiency virus DNA in urethral secretions in men: association with gonoccocal urethritis and CD4 cell depletion. J Infect Dis 1995, 172:1469-1474.
2. Eron JJ, Gilliam B, Fiscus S, Dyer J, Cohen MS. HIV-1 shedding and chlamydial urethritis. JAMA 1996, 275:36.
3. Ghys PD, Fransen K, Diallo MO, Ettiegne-Traore V, Coulibaly IM, Yeboue KM, et al. The association between cervicovaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Cote d'Ivoire. AIDS 1997, 11:F85-F93.
4. Cohen MS, Hoffman IF, Royce RA, Kazembe P, Dyer JR, Daly CC, et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. Lancet 1997, 349:1868-1873.
5. McClelland RS, Wang CC, Mandaliya K, Overbaugh J, Reiner MT, Panteleeff DD, et al. Treatment of cervicitis is associated with decreased cervical shedding of HIV-1. AIDS 2001, 15: 105-110.
6. Dyer JR, Eron JJ, Hoffman IF, Kazembe P, Vernazza PL, Nkata E, et al. Association of CD4cell depletion and elevated blood and seminal plasma human immunodeficiency virus type 1 (HIV-1) RNA concentrations with genital ulcer disease in HIV-1-infected men in Malawi. J Infect Dis 1998, 177:224-227.
7. World Health Organization/Global Programme on AIDS. Management of Sexually Transmitted Diseases. WHO/GPA/TEM/94.1. WHO: Geneva; 1994.
8. Grosskurth H, Mosha F, Todd J, Mwijarubi E, Klokke A, Senkoro K, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet 1995, 346:530-536.
9. Médecins Sans (Frontièrs Belgium)/Addis Ababa Health Bureau Joint Initiative. Sexually Transmitted Diseases Syndrome Therapeutic Guidelines. Médecins Sans Frontièrs: Addis Ababa, Ethiopia; 1999.
10. Dyer JR, Gilliam BL, Eron JJ, Grosso L, Cohen MS, Fiscus SA. Quantitation of human immunodeficiency virus type 1 RNA in cell free seminal plasma: comparison of NASBA with Amplicor reverse transcription-PCR amplification and correlation with quantitative culture. J Virol Methods 1996, 60:161-170.
11. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991, 29:297-301.
12. Vernazza PL, Eron JJ, Fiscus SA, Cohen MS. Sexual transmission of HIV: infectiousness and prevention. AIDS 1999, 13:155-166.
13. Vuylsteke, Laga M, Alary M, Gerniers MM, Lebughe JP, Nzila N, et al. Clinical algorithm for the screening of women for gonococcal and chlamydial infection: Evaluation of pregnant women and prostitutes in Zaire. J Infect Dis 1993, 17:82-88.
14. Wawer MJ, Sewankambo NK, Serwadda D, Quinn TC, Paxton LA, Kiwanuka N, et al. Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Lancet 1999, 353:525-535.
15. Hudson CP. Syndromic management for sexually transmitted diseases: back to the drawing board. Int J STD AIDS 1999, 10:423-434.
16. Theus SA, Harrich DA, Gaynor R, Radolf JD, Norgard MV. Treponema pallidum, lipoproteins, and synthetic lipoprotein analogues induce human immunodeficiency virus type 1 gene expression in monocytes via NF-kappaB activation. J Infect Dis 1998, 177:941-950.
17. Goulston C, McFarland W, Katzenstein D. Human immunodeficiency virus type 1 RNA shedding in the female genital tract. J Infect Dis 1998, 177:1110-1103.
18. Kovacs A, Chan LS, Chen ZC, Meyer WA, Muderspach L, Young M, et al. HIV-1 RNA in plasma and genital tract secretions in women infected with HIV-1. J Acquir Immun Defic Syndr 1999, 22:124-131.
19. Hart CE, Lennox JL, Pratt-Palmore M, Wright TC, Schinazi RF, Evans-Strickfaden T, et al. Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract. J Infect Dis 1999, 179:871-882.
20. Kovacs A, Wasserman SS, Burns D, Wright DJ, Cohn J, Landay A, et al. Determinants of HIV-1 shedding in the genital tract of women. Lancet 2001, 358:1593-1601.